Bobak R. Azamian - Mar 24, 2025 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
President/CEO and Board Chair, Director
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Mar 24, 2025
Transactions value $
-$300,000
Form type
4
Date filed
3/26/2025, 04:47 PM
Previous filing
Mar 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale -$300K -6K -0.72% $50.00 824K Mar 24, 2025 By the Bobak Azamian Living Trust established April 16, 2018 F1, F2
holding TARS Common Stock 53.6K Mar 24, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.
F2 The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.